Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling
Authors:
Open Access
- 7 December 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 92 (1) , 140-146
Abstract
Although ErbB receptors have been implicated in the progression of prostate cancer, little is known about proteins that may mediate their interactions with the androgen receptor (AR). Ebp1, a protein cloned via its association with the ErbB3 receptor, binds the AR and inhibits androgen-regulated transactivation of wild-type AR in COS cells. As the complement of coregulators in different cells are important for AR activity, we determined the effect of Ebp1 on AR function in prostate cancer cell lines. In addition, we examined the regulation of Ebp1 function by the ErbB3/4 ligand heregulin (HRG). In this study, we demonstrate, using several natural AR-regulated promoters, that Ebp1 repressed transcriptional activation of wild-type AR in prostate cancer cell lines. Downregulation of Ebp1 expression in LNCaP cells using siRNA resulted in activation of AR in the absence of androgen. Ebp1 associated with ErbB3 in LNCaP cells in the absence of HRG, but HRG induced the dissociation of Ebp1 from ErbB3. In contrast, HRG treatment enhanced both the association of Ebp1 with AR and also the ability of Ebp1 to repress AR transactivation. These studies suggest that Ebp1 is an AR corepressor whose biological activity can be regulated by the ErbB3 ligand, HRG.Keywords
This publication has 46 references indexed in Scilit:
- The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trialThe Prostate, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Androgen Receptors in Prostate CancerJournal of Urology, 2003
- Neuregulin promotes autophagic cell death of prostate cancer cellsThe Prostate, 2003
- Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1Oncogene, 2002
- Analysis of the Expression Pattern of Ebp1, an ErbB-3-Binding ProteinBiochemical and Biophysical Research Communications, 2001
- Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingOncogene, 2001
- The EGFR family and its ligands in human cancerEuropean Journal of Cancer, 2001
- Inhibition of Histone Deacetylation Augments Dihydrotestosterone Induction of Androgen Receptor Levels: An Explanation for Trichostatin A Effects on Androgen-Induced Chromatin Remodeling and Transcription of the Mouse Mammary Tumor Virus PromoterExperimental Cell Research, 1999
- ErbB kinases and NDF signaling in human prostate cancer cellsOncogene, 1997